You are here

Eisai

For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst

Fierce Pharma

Mon, 05/19/25 - 10:25 pm

Alzheimer's disease

Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi

Tip Ranks

Thu, 05/15/25 - 10:31 pm

Alzheimer's disease

Leqembi is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

Stock Titan

Tue, 04/15/25 - 07:49 pm

Alzheimer's disease

Five Biggest Drug Face-Offs in Pharma History

BioSpace

Wed, 04/9/25 - 11:38 am

Bristol Myers Squibb

US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree

Pharma Voice

Mon, 04/7/25 - 10:06 am

Alzheimer's disease

Eisai lays out road map to blockbuster sales projections for Leqembi's 'milestone' 2027 year

Fierce Pharma

Tue, 03/25/25 - 09:43 pm

Alzheimer's disease

Eisai's abandoned Enhertu challenger set to live on at BlissBio

Fierce Biotech

Fri, 03/21/25 - 11:34 am

What’s driving pharma’s layoffs in 2025

Pharma Voice

Mon, 03/10/25 - 09:27 am

CRISPR Therapeutics

Atara Biotherapeutics

Bristol Myers Squibb

NICE agrees to look again at Alzheimer's drug Leqembi

Pharmaphorum

Thu, 03/6/25 - 10:59 am

Alzheimer's disease

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach

Pharma Voice

Tue, 03/4/25 - 09:51 am

Voyager Therapeutics

Alzheimer's disease

Australia stands firm on 'no' to Alzheimer's drug Leqembi

Pharmaphorum

Mon, 03/3/25 - 10:53 am

Alzheimer's disease

Leqembi, after delay, gets back on track toward EU approval

BioPharma Dive

Sun, 03/2/25 - 09:35 pm

Alzheimer's disease

Eisai to part ways with 121 employees amid new US restructuring effort

Fierce Pharma

Thu, 02/27/25 - 09:29 pm

Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym

Fierce Pharma

Tue, 02/11/25 - 09:41 pm

Alzheimer's disease

Europe to review safety data for Eisai-Biogen Alzheimer's drug

Marketscreener

Fri, 01/31/25 - 11:16 am

Alzheimer's disease

Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales

BioPharma Dive

Mon, 01/27/25 - 11:24 am

Alzheimer's disease

Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial

Fierce Pharma

Fri, 01/24/25 - 11:30 am

clinical trials

gastroesophageal adenocarcinoma

Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033

Clinical Trials Arena

Fri, 01/10/25 - 11:18 am

Alzheimer's disease

Eisai unit hands over $46M for Japanese rights to Newron’s schizophrenia add-on

Fierce Biotech

Sun, 12/15/24 - 10:48 pm

Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome

Fierce Pharma

Mon, 11/18/24 - 06:36 pm

Pages